Your browser doesn't support javascript.
loading
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study.
Tibes, Raoul; Borad, Mitesh J; Dutcus, Corina E; Reyderman, Larisa; Feit, Kevie; Eisen, Andrew; Verbel, David A; Von Hoff, Daniel D.
Affiliation
  • Tibes R; Laura & Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA. raoul.tibes@nyumc.org.
  • Borad MJ; Mayo Clinic, Scottsdale Campus, Scottsdale, AZ, USA.
  • Dutcus CE; Eisai Inc., Woodcliff Lake, NJ, USA.
  • Reyderman L; Eisai Inc., Woodcliff Lake, NJ, USA.
  • Feit K; Eisai Inc., Woodcliff Lake, NJ, USA.
  • Eisen A; Translational Medicine Consulting, Rockville, MD, USA.
  • Verbel DA; Eisai Inc., Woodcliff Lake, NJ, USA.
  • Von Hoff DD; Translational Genomics Research Institute, Phoenix, AZ, USA.
Br J Cancer ; 118(12): 1580-1585, 2018 06.
Article in En | MEDLINE | ID: mdl-29867224
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lactones / Melanoma / Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lactones / Melanoma / Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article